Comparative analysis of functional and economic outcomes of prostatic urethral lift and water vapor thermal therapy for male LUTS: A French perspective.

Introduction: Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are common in aging men, significantly impacting quality of life and healthcare costs. While transurethral resection of the prostate (TURP) remains the traditional standard for treatment, minimally invasive surgical therapies (MISTs) like Rezum™ (water vapor thermal therapy, WVTT) and Urolift™ (prostatic urethral lift, PUL) have emerged as effective alternatives. Both methods promise symptom relief with minimal invasiveness, yet a comparative medico-economic analysis is lacking.